Stay updated on ABTL0812 in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the ABTL0812 in Pancreatic Cancer Clinical Trial page.

Latest updates to the ABTL0812 in Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe web page has added specific names of compounds and a facility name, while removing several terms related to locations and various antineoplastic agents.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
- Check36 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to ABTL0812 in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABTL0812 in Pancreatic Cancer Clinical Trial page.